Disclosure of interest: All authors have nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P153 - ESOC25-601 MIDDLE MENINGEAL ARTERY EMBOLIZATION IN A COHORT OF PATIENTS ON ANTITHROMBOTIC THERAPY Eduardo Fandio 1 , Isabel Bermudez-Coronel 1 , Mara Prez 1 , Jose Carlos Mendez 1 , Rodrigo Carrasco 1 , Vctor Rodrguez 1 , Lara Castellanos 1 , Eva Cortina 1 , Karolina Monsior 1 , Luis Ley 1 1 Hospital Universitario Ramn y Cajal, Madrid, Spain Background and Aims: To evaluate the effectiveness and safety of middle meningeal artery embolization in chronic subdural hematoma patients on antithrombotic therapy
For patients with neurological involvement, maintenance injections are typically given every 2 months
At Formation, every peptide used in patient treatment is sourced exclusively from licensed compounding pharmacies that produce human-grade medications
is a high-tech enterprise specializing in the research and development, production and sales of veterinary drugs
